Table 5.

Review of the literature on the proportion of eyelid tumors in Asians

Author(s), year	Country	Patients with malignant eyelid tumors,n	BCC, %	SCC, %	SGC, %	Miscellaneous tumors, %	Most common malignant eyelid tumor
Abeet al.[17], 1983	Japan	52	33	48	13	6	SCC
Ni et al. [33], 1983	China	525	47	10	33	10	BCC
Sihota et al. [15], 1996	India	178	30	30	33	7	SGC
Abdi et al. [36], 1996	India	85	39	22	27	12	BCC
Dai et al. [27], 1997	China	960	37	8	31	24	BCC
Lee et al. [29], 2000	Singapore	325	84	3	10	2	BCC
Wang et al. [16], 2003	Taiwan	127	62	9	24	5	BCC
Changet al. [30], 2003	Taiwan	18	78	6	17	0	BCC
Obata et al. [24], 2005	Japan	24	38	0	38	25	BCC, SGC
Pornpanich et al. [28], 2005	Thailand	32	41	6	38	15	BCC
Takamura et al. [34], 2005	Japan	38	40	11	29	21	BCC
Lin et al. [14], 2006	Taiwan	1,121	65	13	8	14	BCC
Xu et al. [12], 2008	China	363	41	5	39	15	BCC
Kumar[8], 2010	Nepal	37	24	27	41	8	SGC
Mak et al. [35], 2011	China	36	75	6	11	8	BCC
Kaleet al. [10], 2012	India	85	48	14	31	7	BCC
Lim et al. [31], 2012	Singapore	333	82	4	11	5	BCC
Wang et al. [7], 2013	China and Korea	75	48	9	29	15	BCC
Hussainet al. [11], 2013	Pakistan	222	59	32	7	3	BCC
Bagheri et al. [32], 2013	Iran	100	83	8	6	3	BCC
Ho et al. [13], 2013	China	28	43	18	7	32	BCC
Ramya et al. [21], 2014	India	24	27	22	41	10	SGC
Krishnamurthy et al. [23], 2014	India	19	26	21	32	21	SGC
Rathod et al. [25], 2015	India	39	41	10	41	8	BCC, SGC
Huanget al. [9], 2015	Taiwan	227	58	10	21	11	BCC
Karanet al. [20], 2016	India	9	33	11	56	0	SGC
Mohanet al. [19], 2017	India	41	15	22	24	39	SGC
Guptaet al. [18], 2017	India	9	22	11	44	22	SGC
Jangir et al. [26], 2017	India	17	29	24	47	0	SGC
Present study, 2018	India	536	18	24	53	4	SGC

BCC, basal cell carcinoma; SCC, squamous cell carcinoma; SGC, sebaceous gland carcinoma.